A carregar...
Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines
Significant advances have been made in the design, discovery, and development of nanoparticles for cancer treatment in recent years. However, despite promising results in preclinical animal models, cancer nanomedicines often fail in clinical trials during phase II and phase III testing due to lack o...
Na minha lista:
| Publicado no: | Adv Healthc Mater |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7473451/ https://ncbi.nlm.nih.gov/pubmed/32367687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.202000110 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|